14 CRISPR-Cas9 genome editing creates targeted double strand breaks (DSBs) in eukaryotic cells that are 15 processed by cellular DNA repair pathways. Co-administration of single stranded oligonucleotide donor 16 DNA (ssODN) during editing can result in high-efficiency (>20%) incorporation of ssODN sequences into 17
the break site. This process is commonly referred to as homology directed repair (HDR) and here referred 18 to as single stranded template repair (SSTR) to distinguish it from repair using a double stranded DNA 19 donor (dsDonor). The high efficacy of SSTR makes it a promising avenue for the treatment of genetic 20 diseases 1,2 , but the genetic basis of SSTR editing is still unclear, leaving its use a mostly empiric process. 21
To determine the pathways underlying SSTR in human cells, we developed a coupled knockdown-editing 22 screening system capable of interrogating multiple editing outcomes in the context of thousands of 23 individual gene knockdowns. Unexpectedly, we found that SSTR requires multiple components of the 24 Fanconi Anemia (FA) repair pathway, but does not require Rad51-mediated homologous recombination, 25 distinguishing SSTR from repair using dsDonors. Knockdown of FA genes impacts SSTR without altering 26 break repair by non-homologous end joining (NHEJ) in multiple human cell lines and in neonatal dermal 27 fibroblasts. Our results establish an unanticipated and central role for the FA pathway in templated repair 28 from single stranded DNA by human cells. Therapeutic genome editing has been proposed to treat genetic 29 disorders caused by deficiencies in DNA repair, including Fanconi Anemia. Our data imply that patient 30 genotype and/or transcriptome profoundly impact the effectiveness of gene editing treatments and that 31 adjuvant treatments to bias cells towards FA repair pathways could have considerable therapeutic value. 32 33
Main Text 34
The type II CRISPR endonuclease Cas9 and engineered guide RNA (gRNA) form a 35 ribonucleoprotein (RNP) complex that introduces double stranded breaks (DSBs) at DNA sequences 36 complementary to the 23 bp protospacer-PAM sequence. This activity stimulates two major types of DNA 37 repair within a host cell that are relevant to genome editing: genetic disruption, which creates insertions or 38 deletions (indels) at the cut site and can disrupt functional sequences; and genetic replacement, which 39 incorporates exogenous donor DNA sequences at the cut site, allowing the correction of dysfunctional 40 elements or insertion of new information 3 . Efficient and targeted genetic replacement is particularly exciting, 41 as it holds great promise for the cure of myriad genetic diseases. 42
Despite the rapid adoption of CRISPR-Cas9 genome editing, relatively little is known about which 43 cellular DSB repair pathways underlie Cas9-mediated genetic replacement. This lack of clarity has 44 complicated efforts to better understand and rationally improve the process of genome editing. The 45 pathways responsible for genetic replacement are frequently referred to in aggregate as HDR, which 46 includes DSB repair programmed from dsDonors (both linear and plasmid) requiring several kilobases of 47 homology to the targeted site, as well as synthetic ssODNs with only 100-200 bases of homology to the 48 target 4 . Repair from dsDonors is relatively inefficient in most cell types 5 and is assumed to utilize a repair 49 mechanism paralleling meiotic homologous recombination (HR) 6 . By contrast, SSTR is highly effective in 50 human cells (>20% of alleles) 1,5,7 and broadly conserved among metazoans 8 , but very little is known about 51 the mechanism responsible. While screening human cancer cell lines, we found that SSTR-based genome 52 editing at a given locus can vary from completely ineffective (0% SSTR) to extremely efficient (30% SSTR) 53 depending on the cell background [Extended Data Figure 1 ]. This implies genetic or transcriptional 54 differences that up-or down-regulate gene editing in different contexts. 55
To map the pathways involved in SSTR, we developed a coupled inhibition-editing screening 56 platform that combines individual CRISPR inhibition (CRISPRi) of thousands of genes with Cas9 editing at 57 a single-copy genomically integrated BFP reporter [ Figure 1A ]. Each cell in the screening pool stably 58 expresses a dCas9-KRAB CRISPRi construct as well as a gRNA targeting the TSS of a single gene. This 59 pool is then nucleofected with preformed Cas9-gRNA ribonucleoprotein complex (RNP) targeting the BFP 60 reporter, as well as an ssODN that programs a 3 basepair codon-swap that converts BFP to GFP 7 . The 61 femtomolar affinity between S. pyogenes Cas9 and the gRNA 9 , along with the transient nature of the Cas9 62 RNP 10 strongly disfavors guide swapping between Cas9 molecules, preserving separation between 63
CRISPRi and targeted gene editing. Editing outcomes in each cell are separated by fluorescence activated 64 cell sorting (FACS) and next generation sequencing is used to determine genes whose knockdown leads to 65 enrichment or depletion from each sorted population. [ Figure 1A ]. 66
To enable discovery of relatively low frequency events, we created a focused CRISPRi lentiviral 67 library containing 2,000 genes (10,000 gRNAs, 5 gRNAs targeting each primary gene transcript) with gene 68 ontology terms related to DNA processing [Document S2 GUIDES] 11 . This library was stably transduced at 69 low multiplicity of infection into cells expressing dCas9-KRAB and selected for the gRNA construct for ten 70 days to allow gRNA populations to reach equilibrium and for gRNAs targeting essential genes to drop out 71 of the population. We harvested a sample of cells at this point as a control for comparison with previously 72 published essentiality screens. We then electroporated cells with Cas9 RNP and the BFP-to-GFP ssODN 7 . 73 Under unperturbed conditions, this combination of reporter, RNP, and ssODN yields ~70% gene disruption 74 (no longer BFP+) and ~20% SSTR (BFP edited to GFP) [Extended Data Figure 2 ]. We harvested another 75 sample of cells seven days after electroporation to identify genes whose knockdown is synthetic lethal with 76 a Cas9-induced DSB, as measured by depletion only after introduction of Cas9. To identify genes involved 77 in editing events, we used FACS to separate cells into unedited (BFP+/GFP-), Indel (BFP-/GFP-) and 78 SSTR edited (BFP-/GFP+) populations [ Figure 1A , Extended Data Figure 2 ]. We used Illumina 79 sequencing to measure gRNA abundances in each population, and compared these distributions to the 80 edited unsorted cell population to reveal which target genes promote (gRNA depleted from edited 81 population) or restrict (gRNA enriched from edited population) specific genome editing activities. 82
To benchmark our screening system, we identified essential genes by comparing the library-83 infected dCas9-KRAB CRISPRi cells with cells infected with only the gRNA library and no dCas9-KRAB 84 [Extended Data Figure 3A , Document S3 Essential Genes]. Genes that were depleted after 14 days 85 from the functional CRISPRi cells as compared to the gRNA-only control cells were significantly enriched 86 for critical biological processes (DAVID 12 analysis: proteasome core complex p=8.6e-14 and DNA 87 replication p=1.7e-11). Furthermore, genes we identified as essential reproduced previously published 88 essentiality screens [Extended Data Figure 4A ] 11 , demonstrating that we had achieved stable gene 89 knockdown and robust hit calling from the cell pools. 90
We next investigated genes whose knockdown was synthetic lethal with a Cas9-induced DSB. To identify factors required for SSTR editing, we used FACS to isolate GFP+ cells (that had 106 undergone BFP-to-GFP conversion via SSTR) and measured depletion of gRNAs relative to the unsorted 107 edited pool [ Figure 1B ]. Strikingly, 70% (28/40) of genes annotated in the Fanconi Anemia (FA) pathway 108 were robustly and consistently depleted from the GFP+ population relative to unsorted edited cells. Gene 109 set enrichment analysis 14 verified that DNA repair in general and the FA pathway in particular was a defining feature of SSTR [ Figure 1C ]. Several distinct functional groups within the FA repair pathway were 111 identified as required for SSTR: multiple components of the FA core complex that senses lesions, FA core 112 regulatory components that activate the FANCD2-FANCI heterodimer, downstream effector proteins that 113 repair lesions, and associated proteins that interact with canonical FA repair factors [ Figure 1D ]. Our 114 identification of the FA pathway as central to SSTR was striking, as to the best of our knowledge the FA 115 pathway has not previously been investigated for its role in Cas9 gene editing. 116
We used individual knockdown of FANCA, RAD51, and other DNA repair genes to further 117 investigate the genetic basis of SSTR and dsDonor HDR. Previous reports have indicated the editing 118 outcomes of SSTR are RAD51-independent and ineffective during G2/M 15,16 , while dsDonor HDR is 119 RAD51-dependent 17 , FANCA-dependent 18 , and active during G2/M 19 . Using Cas9 RNPs to edit the same 120 locus with dsDonors and ssODNs in K562 human erythroleukemia cells, we found approximately four-fold 121 higher gene replacement efficiency with ssODNs. Knockdown of FANCA caused statistically significant 122 four-fold reduction in SSTR (p<0.05, Welch's two-sided t-test) and a non-significant two-fold reduction in 123 dsDonor HDR (p=0.22, Welch's two-sided t-test) [ Figure 1E ]. These results highlight the unexpected role 124 of FANCA in SSTR and suggest it might also play some role in HDR. As expected, neither SSTR nor HDR 125 required NHEJ (mediated by LIG4), or the related Alternative End Joining (Alt-EJ) pathway (mediated by 126 PARP1). Notably, we found that knockdown of RAD51 abolished dsDonor HDR but had no effect upon 127 SSTR [Extended Data Figure 5 ]. Taken together, individual knockdown bolsters the hypothesis derived 128 from the primary screen that SSTR is a genetically distinct pathway from dsDonor-mediated HDR. 129
The FA repair pathway is best understood in its capacity to identify and repair interstrand crosslinks 130 (ICLs) throughout the genome, but has recently gained attention for its role in protecting stalled replication 131 forks 20-22 . In the presence of ICLs or a stalled fork, the FA core complex (comprised of FANCA, B, C, E, F, 132 G, L, M, FAAP100, FAAP20, and FAAP24) is required for monoubiquitination and activation of the 133 FANCD2-FANCI heterodimer by UBE2T and FANCL. Monoubiquitination then leads to recruitment of 134 downstream factors that repair the lesion via nucleotide excision repair (NER) or specialized homologous 135 recombination sub-pathways. Subsequent to repair, FANCD2/FANCI is recycled through deubiquitination 136 by USP1 and WDR48. Deactivation of FANCD2/FANCI appears to be a key step in restoring homeostasis, 137 as mutants in USP1 and WDR48 phenocopy classical FA mutants with an increased sensitivity to ICL-138 causing agents. Notably, our screen identified that SSTR depends upon genes that act in every functional 139 category of the FA repair pathway [ Figure 1D ]. SSTR is therefore likely to be a central activity of the FA 140 repair pathway as opposed to a moonlighting activity of one or more FA genes. 141
To further explore the genetic basis of SSTR, we used CRISPRi to stably knock down seven 142 separate FA repair genes that operate at different places in the FA pathway and quantified the frequency of 143 Cas9-mediated SSTR at multiple loci. Knockdown of FANCA, FANCD2, FANCE, FANCF, FANCL, HELQ, 144 UBE2T, USP1, and WDR48 all substantially decreased SSTR at a stably integrated BFP reporter, as 145 measured by flow cytometry [Figure 2A ]. Stable cDNA re-expression of each factor restored wildtype 146 levels of SSTR, demonstrating that CRISPRi was specific to the targeted gene and that ablation of each 147 gene was solely responsible for the loss of SSTR. Re-expression of an FA factor in the context of its 148 knockdown increased editing efficiency up to 8-fold. These results demonstrate that multiple genes in 149 different parts of the FA repair pathway are required for SSTR editing, that their presence is necessary for 150 efficient SSTR, and that re-expression is sufficient to restore SSTR. 151
In addition to the FA pathway's well-characterized roles in ICL repair, there is an emerging view that 152 it plays additional roles in preserving genome stability. FA genes protect against aberrant chromosomal 153 structures and replication stress via specialized subcomplexes that in part depend upon particular 154 helicases, including Bloom's helicase (BLM) and the 3'-5' ssDNA helicase HELQ. We found that siRNA 155 knockdown of BLM had no effect on SSTR [Extended Data Figure resolution of replication stress 23 , HELQ directly interacts with FANCD2/FANCI with unknown functional 161 significance 24 . HELQ also interacts with multiple recombination subcomplexes, including BCDX2 (RAD51B, 162 RAD51C, RAD5D, and XRCC2) and CX3 (RAD51C-XRCC3). These complexes could promote 163 recombination between the ssODN and genomic DNA, and we asked if these complexes also impact 164
SSTR. 165
We found that RAD51C is required for SSTR, but RAD51B and XRCC2 are not. This suggests that 166 has been reported to act downstream of RAD51 filament formation 25 , but we found that RAD51 itself is 169 dispensable for SSTR [ Figure 1B , Extended Data Figure 5 ]. We anticipate that future work to 170 characterize how the FA pathway interacts with downstream effectors, especially polymerases and genes 171 that mediate recombination, will provide valuable insights into the mechanism of SSTR and its interaction 172 with other pathways that maintain genome stability. absence of an ssODN, we found that knockdown of FA repair genes did not significantly increase NHEJ 182 frequency on its own [Extended Data Figure 9 ]. We found similar results at the BFP locus when 183 measuring editing outcomes by Illumina sequencing. These results imply that the FA repair pathway acts to 184 divert repair events that would otherwise be repaired by NHEJ into SSTR outcomes. This model parallels 185
proposed roles for the FA pathway in balancing NHEJ and HR repair frequencies during ICL repair 26, 27 and 186 balancing Alt-EJ, NHEJ, and HDR repair outcomes near DSBs 28 . 187
To determine if FA repair genes are responsible for SSTR in primary human cells, we edited human 188 neonatal dermal fibroblasts at HBB Glu6. These fibroblasts have previously been shown to be capable of 189 SSTR repair, albeit at lower levels than many cell lines 15 . Untreated or mock siRNA treated fibroblasts 190 exhibited approximately 5% SSTR at the HBB locus, as measured by Illumina sequencing. siRNA 191 knockdown of either FANCA or FANCE led to an approximately five-fold reduction in SSTR [ Figure 2C ]. 192 Therefore, the FA repair pathway is tightly linked to SSTR in at least one primary human cell type. 193
The sequence outcomes of genomic disruption (indels) following Cas9-induced DSBs are often 194 nonrandom and surprisingly consistent at individual loci, leading to an emerging model that repair did not measurably alter the SNP conversion tracts. These results reinforce our earlier observation that FA 208 repair pathway inactivation specifically inhibits SSTR without altering the frequency of indels. Additionally, 209 the molecular sequence outcomes of NHEJ are unaffected by the FA pathway. Instead, the FA pathway is 210 restricted to SSTR repair and the balance between NHEJ and SSTR, but does not play a direct role in 211 error-prone end-joining pathways. 212
In sum, we have found that multiple functional complexes within the FA repair pathway are 213 necessary for Cas9-mediated SSTR. Genome editing is commonly grouped into two categories, genetic 214 disruption and genetic replacement, based on sequence outcomes 2 . Our results demonstrate that final 215 genetic replacement outcomes using different templates (ssODN vs dsDonors) are identical at the 216 sequence level but stem from completely different pathways [ Figure 4 ]. Specifically, information from 217 double stranded DNA templates and genomic DNA are incorporated using Rad51-dependent processes, 218 but single stranded DNA templates are incorporated through the FA pathway. A great deal of work has 219 focused on improving HDR during gene editing by activating Rad51-mediated processes, including Rad51 220 agonist small molecules 30 and strategies to stimulate recruitment of Rad51 throughout the cell cyle 31 . Our 221 results indicate that future efforts to the activate FA pathway could be invaluable during gene editing for 222 research or therapeutic uses. 223
Cas9-mediated genome editing holds great promise for the treatment of genetic diseases such as 224 sickle cell disease and Fanconi Anemia. High rates of gene editing are typically required for therapeutic 225 editing applications, but editing efficiencies can differ greatly between cells. Without knowledge of the 226 pathways responsible for genetic replacement outcomes and the activity of those pathways in the targeted 227 cell type, it was previously difficult to rationalize why editing might fail in one application while succeeding 228 in another. Our results predict that human cell types with intrinsic repair preferences that impact the FA 229 pathway will be more or less capable of SSTR [Extended Data Figure 1] . The expression level of FA-230 related factors could in future be useful as a biomarker for patient cell "editability", and treatments that 231 enhance the activity of the FA pathway could be especially valuable in difficult to edit cells. For example, 232
we found that complementing FA pathway knockdown yields up to 8-fold increase in editing efficiency in 233 cell lines [ Figure 2A ]. This suggests that reactivating the FA pathway could be valuable in cases where it 234 has been disrupted, such as in Fanconi Anemia itself. Small molecule activators of the FA pathway remain 235 to be identified, but our results suggest that transiently increasing the levels of FA proteins could 236 complement patient-specific defects to enable lasting gene editing cures. More broadly, our results suggest 237 that patient genotype or transcriptome could increase or decrease the effectiveness of therapeutic 238 treatments in previously unanticipated ways. Deeper understanding of the molecular basis of SSTR and 239 dsDonor HDR is likely to suggest new biomarkers to 'match' patient genotype with therapeutic editing 240 strategy. 241
Finally, our data imply that the default repair pathway for DSBs, especially DSBs introduced by 242 Cas9, is end joining, and that the activity of the FA repair pathway determines whether many events will 243 instead be repaired by SSTR [ Figure 2A, Figure 4 ]. Cas9 is very stable on genomic targets 7,32 , and so it is 244 possible that Cas9 itself is recognized as an interstrand crosslink or roadblock within the genome. 245
However, we disfavor this hypothesis because FA knockdown only impacts SSTR without directly affecting 246 indels. Instead, we hypothesize that Cas9-stimulated repair using an ssODN template mimics some 247 substrate of the FA pathway, such as a stalled replication fork. We note that SSTR is much more efficient 248 than HDR from a double stranded DNA template [ Figure 1E ], to the extent that in many cell lines, the most 249 common single allele at an edited locus is the product of SSTR [ Figure 3B ]. This ability raises intriguing 250 questions about genome integrity in the presence of single stranded DNA exposed by R-loops, replication 251 crises, or viral infection. The FA pathway has already been implicated in replication crises, and future work 252 to address remaining questions could provide insight into mechanisms by which human cells maintain their 253 genomes. 254 255 256 
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